Some say left ventricular intracardiac echogenic focus (ICEF) in the second trimester may signal the presence of Down syndrome.
Some say left ventricular intracardiac echogenic focus (ICEF) in the second trimester may signal the presence of Down syndrome. Others believe you can ignore it in an otherwise healthy normal fetal heart. Starting out with 62 cases of ICEF among patients who also had a triple marker screen performed, researchers from the University of Illinois at Chicago found that none of the cases with a negative triple screen and no other cardiac abnormalities (58/62 or 93.5%) had trisomy 21. Put another way, you can probably tell patients with isolated ICEF on a 2nd-trimester U/S, plus a negative triple screen, that the risk of Down syndrome is "not increased above their age-related risk."
Kemp A, Colon M. The significance of a fetal intracardiac echogenic focus in the face of normal triple-marker testing. Obstet Gynecol. 2005;105(4 suppl):52S.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More